Biotech News
Provided courtesy of: http://news.search.yahoo.com/news
- CFI's 'Omics Grants Broad in Scope (GenomeWeb News)
- Fri, 03 Jul 2009 13:48:09 GMT - NEW YORK (GenomeWeb News) – The nearly C$670 million ($576.8 million) that the Canada Foundation for Innovation recently pumped into research projects and infrastructure will fund a range of genomics and proteomics studies and institutes spread across the nation.
- Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology (redOrbit)
- Fri, 03 Jul 2009 13:59:54 GMT - NEW BRUNSWICK, N.J., July 3 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced that the initial offering period of its tender offer for all outstanding shares of common stock of Cougar Biotechnology, Inc.
- Q&A: U of Zurich Team Develops Protein Inference Method to Eliminate Shotgun Proteomics Ambiguities (GenomeWeb News)
- Thu, 02 Jul 2009 14:32:53 GMT - In a study published June 22 online in Genome Research , researchers describe a new peptide classification and protein inference method that helped them identify around 3,500 proteins in pollen — around 13 times the previously reported pollen proteome.
- Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances The Effectiveness Of Standard Cancer Chemotherapy In ... (Medical News Today)
- Fri, 03 Jul 2009 11:10:33 GMT - Lixte Biotechnology Holdings (OTC Bulletin Board: LIXT) announced that investigators of the National Institute of Neurological Disorders and Stroke (NINDS) and the National Cancer Institute (NCI), National Institutes of Health and Lixte reported that its novel compound, LB-1.2, enhances the effectiveness of two standard chemotherapy drugs in mouse models of human cancers.
- Cougar Biotechnology Announces Successful Completion of Johnson & Johnson's Initial Tender Offer and Commencement of ... (Business Wire via Yahoo! Finance)
- Fri, 03 Jul 2009 16:00:00 GMT - LOS ANGELES----Cougar Biotechnology, Inc. announced today that the initial offering period of Johnson & Johnson's tender offer for all the outstanding shares of Cougar common stock expired at midnight on July 2, 2009.
- Cardiff Univ. Uses $6.6M for Neuro-Genetics and Genomics Center (GenomeWeb News)
- Fri, 03 Jul 2009 15:33:13 GMT - NEW YORK (GenomeWeb News) – Cardiff University in Wales has established a new center to study the genetic underpinnings of mental illnesses, and said that it will be funded with over £4 million ($6.6 million) from sources within the UK and from its own coffers.
- Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances the Effectiveness of Standard Cancer Chemotherapy in ... (redOrbit)
- Thu, 02 Jul 2009 14:46:04 GMT - EAST SETAUKET, N.Y., July 2 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings (OTC Bulletin Board: LIXT) announced today that investigators of the National Institute of Neurological Disorders and Stroke (NINDS) and the National Cancer Institute (NCI), National Institutes of Health and Lixte reported that its novel compound, LB-1.2, enhances the effectiveness of two standard chemotherapy ...
- Early Glance: Biotechnology companies (INO News)
- Thu, 02 Jul 2009 14:51:38 GMT - (AP:NEW YORK) Shares of some top biotechnology companies are down at 10 a.m.: Amgen fell $.74 or 1.4 percent, to $52.02. Biogen Idec fell $.64 or 1.4 percent, to $46.13.
- Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances the Effectiveness of Standard Cancer Chemotherapy in ... (PR Newswire via Yahoo! Finance)
- Thu, 02 Jul 2009 13:00:00 GMT - Lixte Biotechnology Holdings announced today that investigators of the National Institute of Neurological Disorders and Stroke and the National Cancer Institute , National Institutes of Health and Lixte reported that its novel compound, LB-1.2, enhances the effectiveness of two standard chemotherapy drugs in mouse models of human cancers.
- BlueGnome to Distribute PicoPlex Technology from Rubicon Genomics (Business Wire via Yahoo! Finance)
- Wed, 01 Jul 2009 19:31:00 GMT - ANN ARBOR, Mich.----Rubicon Genomics, Inc., a developer of pre-analytical amplification products that enable optimal performance of advanced genetic analysis tools, announced today that it has reached agreement with BlueGnome to non-exclusively market its PicoPlexâ„¢ technology to In Vitro Fertilization researchers under the name SurePlex DNA Amplification System as part of the BlueGnome 24sure ...
- Cloned horses latest move for controversial field
- Friday Mar 31, 2006 - WASHINGTON (Reuters) - The company that cloned the first horse to be sold commercially said on Thursday it plans to market 22 similar animals before 2008, marking another step forward for the controversial technology.
- Biologists Take Big Step to Keep Park's Little Cutthroats From Being Devoured
- Tuesday Nov 8, 2005 - YELLOWSTONE NATIONAL PARK, Wyo. - An unusual fishing season just ended on Yellowstone Lake. The take included 36,000 lake trout caught, killed and sunk to the bottom of the lake. And the fishers are not finished.
- A Special Drug Just for You, at the End of a Long Pipeline
- Tuesday Nov 8, 2005 - A new drug for acne, Aczone, was approved in July, but with a catch. The Food and Drug Administration said it would require that patients first be tested for an enzyme deficiency that could put them at risk of developing anemia from the drug.
- U.S. companies to launch corn-based socks in Japan
- Tuesday Nov 8, 2005 - TOKYO (Reuters) - The Chicago White Sox may have won baseball's World Series, but the corn socks are coming to Japan. Biodegradable socks, made from corn-derived fiber and manufactured by U.S. hosiery makers, should make their worldwide debut on Japanese store shelves sometime next year, industry officials said on Tuesday.
- New "chip" could provide quick bird flu test
- Tuesday Nov 8, 2005 - WASHINGTON (Reuters) - A new "chip" can test for 11 different influenza strains, including avian flu, in less than a quarter of the time it now takes to diagnose flu in patients, U.S. researchers said on Monday.
- Prince Charles urges environment moves
- Tuesday Nov 8, 2005 - SAN FRANCISCO (Reuters) - Britain's Prince Charles and his wife, Camilla, toured a landmark San Francisco building renovated to showcase organic foods on Monday and followed the visit by telling California business leaders that urgent action is needed to address environmental challenges.
- Past pandemics that ravaged Europe
- Monday Nov 7, 2005 - In 430BC, during the Peloponnesian war against their great rival Sparta, the people of Athens were hit by a deadly disease that has defied diagnosis to this day.
- U. makes a healing 'bio-paper'
- Saturday Nov 5, 2005 - (Deseret Morning News) An emerging branch of medicine called "organ printing" takes a patient's own healthy cells and uses a printer, cell-based "bio-ink" and "bio-paper" to create tissue to repair a damaged organ.
- Americans split over buying cloned meat: poll
- Friday, Nov 4, 2005 - WASHINGTON (Reuters) - Two-thirds of U.S. consumers said they would either buy or consider buying meat and milk made from cloned animals if the U.S. government declared cloning safe, according to the results of a public opinion poll released on Friday.
- EU authorizes GMO maize type by legal rubberstamp
- Monday, August 8, 2005 - The European Union authorized imports of a genetically modified (GMO) maize on Monday, the third GMO product to win approval since the EU ended its unofficial biotech ban last year, officials said.
- Cloning Man’s Best Friend
- Friday, August 6, 2005 - Hwang Woo-suk, the stem-cell pioneer who led the team that cloned the world’s first dog, explains why they did it and why they believe Snuppy could benefit all of mankind.
- Ghana stops importation of GM Foods
- Thursday, July 28, 2005 - Ghana has taken a strong stance against the importation and cultivation of Genetically Modified (GM) foods in Ghana.
- GM potato uses frog gene to resist pathogens
- Thursday, July 28, 2005 - A chemical that South American frogs excrete from their skin could protect potatoes and other crops from a range of diseases, according to biotechnologists in Canada.
- Skin Cancer Breakthrough in an Egg
- Sunday, July 24, 2005 - CHICKEN eggs containing a drug that can target and treat skin cancer have been produced by Scottish scientists.
- Pakistan, India And US Biotechnology Ties
- Monday, July 11, 2005 - All three countries Pakistan, India and USA are building closer science ties with each other in a range of fields spanning crops biotechnology to overcome its agriculture issues. Pakistan stands to gain tremendously from the tripartite planning meeting on agricultural biotechnology held at Lahore at the end of May 2005.
- ARS to be part of new team improving Cassava
- Friday, July 11, 2005 - Cassava, one of the most important food crops in Africa, is about to undergo an extreme makeover in a multimillion-dollar project that will include an Agricultural Research Service scientist as part of the interdisciplinary team.
- Biotech acreage on the rise across U.S.
- Saturday, July 09, 2005 - As part of the latest NASS acreage survey, farmers’ use of biotechnology-derived crops was detailed. The numbers aren’t growing by leaps and bounds lately, but they are growing.